نتایج جستجو برای: s lymphoma nhl

تعداد نتایج: 809197  

Journal: :iranian journal of cancer prevention 0
fawzi irshaid irshaid dept. of biological sciences, faculty of science, al al-bayt university, al-mafraq, jordan khaled tarawneh . dept. of biological sciences, faculty of science, mutah university, mutah, jordan aisha alshdefat mafraq hospital of children and maternity, al-mafraq, jordan fatiha dilmi dept. of biological sciences, faculty of science, al al-bayt university, al-mafraq, jordan adnan jaran dept. of biological sciences, faculty of science, al al-bayt university, al-mafraq, jordan raji al-hadithi dept. of pathology, faculty of medicine, jordan university of sciences and technology, irbid, jordan

background: expression of epstein-barr virus latent member protein-1 (ebv lmp-1) and loss of p16 protein expression are documented in lymphoma, indicating a relationship between them, but this relationship is not clear and sometimes contradictory. thus, this study was conducted to examine the relationship between the loss of p16 and ebv lmp-1 expression in jordanian patients diagnosed with lymp...

2015
Gabrielle Bradshaw Heidi G. Sutherland Emily T. Camilleri Rodney A. Lea Larisa M. Haupt Lyn R. Griffiths

The methylenetetrahydrofolate reductase (MTHFR) gene codes for the MTHFR enzyme which plays a key role in the pathway of folate and methionine metabolism. Polymorphisms of genes in this pathway affect its regulation and have been linked to lymphoma. In this study we examined whether we could detect an association between two common non-synonymous MTHFR polymorphisms, 677C > T (rs1801133) and 12...

2016
A León-Suárez P Roldán-Sarmiento M A Gómez-Sámano A Nava-De la Vega V M Enríquez-Estrada F J Gómez-Pérez D Cuevas-Ramos

Non-Hodgkin lymphoma (NHL) is a hematological tumor caused by abnormal lymphoid proliferation. NHL can arise in any part of the body, including central nervous system (CNS). However, pituitary involvement is a quite rare presentation. The diffuse large B-cell lymphoma (DLBCL) is the most common subtype when pituitary is infiltrated. Here, we report a case of pituitary infiltration of NHL DLBCL ...

Journal: :Blood 2008
Karin Ekström Smedby Claire M Vajdic Michael Falster Eric A Engels Otoniel Martínez-Maza Jennifer Turner Henrik Hjalgrim Paolo Vineis Adele Seniori Costantini Paige M Bracci Elizabeth A Holly Eleanor Willett John J Spinelli Carlo La Vecchia Tongzhang Zheng Nikolaus Becker Silvia De Sanjosé Brian C-H Chiu Luigino Dal Maso Pierluigi Cocco Marc Maynadié Lenka Foretova Anthony Staines Paul Brennan Scott Davis Richard Severson James R Cerhan Elizabeth C Breen Brenda Birmann Andrew E Grulich Wendy Cozen

Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes are lacking. We performed a pooled analysis of self-reported autoimmune conditions and risk of NHL and subtypes, including 29 423 participants in 12 case-control studies. We computed pooled odds ratios (OR) and 95% confidenc...

2017
Geffen Kleinstern Rania Abu Seir Riki Perlman Areej Khatib Ziad Abdeen Husein Elyan Ronit Nirel Gail Amir Asad Ramlawi Fouad Sabatin Paolo Boffetta Eldad J. Dann Meirav Kedmi Martin Ellis Arnon Nagler Dina Ben Yehuda Ora Paltiel

BACKGROUND Risk factors for B-cell non-Hodgkin lymphoma (B-NHL) have not been assessed among Palestinian Arabs (PA) and Israeli Jews (IJ). METHODS In a case-control study we investigated self-reported medical and lifestyle exposures, reporting odds ratios (ORs) and 95% confidence intervals [CIs], by ethnicity, for overall B-NHL and subtypes. RESULTS We recruited 823 cases and 808 healthy co...

2013
Zhi-Zhang Yang Deanna M. Grote Steven C. Ziesmer Bing Xiu Nicole R. Yates Frank J. Secreto Lucy S. Hodge Thomas E. Witzig Anne J. Novak Stephen M. Ansell

While the effect of TGF-β on malignant B cells in non-Hodgkin lymphoma (NHL) has been previously evaluated, studies to specifically define the role of TGF-β in tumor immunity in B-cell NHL are limited. We found that soluble TGF-β, secreted by both lymphoma cells and intratumoral T cells, is present in the serum of patients with B-cell NHL. Soluble TGF-β promoted regulatory T (T(reg)) cells by e...

2017
D Alan Potts Jonathan R Fromm Ajay K Gopal Ryan D Cassaday

Non-Hodgkin lymphomas (NHL) are a heterogeneous group of hematologic malignancies typically treated with multiagent chemotherapy. Rarely, spontaneous remissions can be observed, particularly in more indolent subtypes. The prognosis of aggressive NHL can be predicted using clinical and histopathologic factors. In aggressive B-cell NHL, the importance of MYC and BCL2 proto-oncogene coexpression (...

Journal: :The Tohoku journal of experimental medicine 2004
Atsushi Hoshino Tadao Funato Yasuhiko Munakata Tomonori Ishii Shori Abe Kenichi Ishizawa Ryo Ichinohasama Junichi Kameoka Kuniaki Meguro Takeshi Sasaki

In order to determine the appropriate treatment of malignant lymphoma, it is important to know the degree to which extra-nodal invasion of lymphoma cells has occurred. We amplified complementarity-determining region (CDR) III genes in 64% of lymph node samples at the onset or relapse of B-cell-lineage non-Hodgkin's lymphoma (NHL) in 22 patients. By using a clone-specific CDR III probe in each p...

Journal: :Expert opinion on pharmacotherapy 2014
Prithviraj Bose Michael S Batalo Beata Holkova Steven Grant

INTRODUCTION Bortezomib , the first proteasome inhibitor (PI) to be evaluated in humans, is approved in the USA and Europe for the treatment of patients with multiple myeloma, and in the USA for patients with relapsed mantle cell lymphoma (MCL). AREAS COVERED This review examines the role of bortezomib in the therapy of non-Hodgkin's lymphoma (NHL). Bortezomib may be particularly effective ag...

Journal: :JPMA. The Journal of the Pakistan Medical Association 1992
M Ahmad A H Khan A Mansoor M A Khan S Saeed

A study of histopathological and clinical features of non-Hodgkin's lymphoma in 495 consecutive cases, diagnosed at AFIP during 1984-1989 is presented. Children below the age of 15 years were not included in this study. The relative frequency of non-Hodgkin's lymphoma was 4.29% in our material. Non-Hodgkin's lymphoma was more frequent than Hodgkin's disease, ratio being 2.44:1. Lymphadenopathy ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید